nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—periosteum—periodontitis	0.179	0.317	CbGeAlD
Levonorgestrel—Danazol—CCL2—periodontitis	0.101	1	CrCbGaD
Levonorgestrel—SHBG—neck—periodontitis	0.0617	0.109	CbGeAlD
Levonorgestrel—SHBG—connective tissue—periodontitis	0.0443	0.0784	CbGeAlD
Levonorgestrel—ESR1—neck—periodontitis	0.0435	0.077	CbGeAlD
Levonorgestrel—PGR—connective tissue—periodontitis	0.0399	0.0706	CbGeAlD
Levonorgestrel—PGR—epithelium—periodontitis	0.0378	0.067	CbGeAlD
Levonorgestrel—CYP19A1—connective tissue—periodontitis	0.0359	0.0635	CbGeAlD
Levonorgestrel—AR—connective tissue—periodontitis	0.0318	0.0562	CbGeAlD
Levonorgestrel—ESR1—connective tissue—periodontitis	0.0312	0.0552	CbGeAlD
Levonorgestrel—AR—epithelium—periodontitis	0.0302	0.0534	CbGeAlD
Levonorgestrel—ESR1—epithelium—periodontitis	0.0296	0.0524	CbGeAlD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—VCAM1—periodontitis	0.0167	0.0499	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—IL18—periodontitis	0.0148	0.0442	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen Receptor Pathway—PPARA—periodontitis	0.0114	0.0341	CbGpPWpGaD
Levonorgestrel—PGR—Ovarian Infertility Genes—VDR—periodontitis	0.0112	0.0335	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—VDR—periodontitis	0.00977	0.0292	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—PPARA—periodontitis	0.00824	0.0246	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.00772	0.0231	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—IL1B—periodontitis	0.00772	0.0231	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—VDR—periodontitis	0.00745	0.0223	CbGpPWpGaD
Levonorgestrel—CYP19A1—Ovarian Infertility Genes—VDR—periodontitis	0.00735	0.022	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.00651	0.0195	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—PPARA—periodontitis	0.00628	0.0188	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—VDR—periodontitis	0.00589	0.0176	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—VDR—periodontitis	0.00574	0.0171	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—TNF—periodontitis	0.0056	0.0167	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—SLC52A3—periodontitis	0.00542	0.0162	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.00496	0.0148	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—PPARA—periodontitis	0.00484	0.0145	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TIMP1—periodontitis	0.00468	0.014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.00457	0.0137	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—VDR—periodontitis	0.00453	0.0135	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—IL1RN—periodontitis	0.00453	0.0135	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—VDR—periodontitis	0.00406	0.0121	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00399	0.0119	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—IL10—periodontitis	0.00395	0.0118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.00384	0.0115	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—PPARA—periodontitis	0.00382	0.0114	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL13—periodontitis	0.00374	0.0112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00356	0.0106	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—periodontitis	0.00346	0.0103	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL10—periodontitis	0.00342	0.0102	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—MMP2—periodontitis	0.00339	0.0101	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—periodontitis	0.00336	0.01	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL4—periodontitis	0.00333	0.00995	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00327	0.00977	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ACP5—periodontitis	0.00319	0.00955	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—VDR—periodontitis	0.00313	0.00936	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—periodontitis	0.00305	0.0091	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—NOS2—periodontitis	0.00301	0.00899	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP1—periodontitis	0.00291	0.0087	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00286	0.00853	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.0027	0.00807	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—periodontitis	0.00263	0.00785	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—periodontitis	0.0026	0.00776	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—MMP2—periodontitis	0.00258	0.00772	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CCL2—periodontitis	0.00237	0.00707	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00235	0.00704	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL10—periodontitis	0.00234	0.00699	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IFNG—periodontitis	0.00231	0.0069	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00228	0.00681	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—GGT1—periodontitis	0.00226	0.00674	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—periodontitis	0.00218	0.00653	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CXCL8—periodontitis	0.00215	0.00641	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—IFNG—periodontitis	0.00206	0.00616	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00204	0.00611	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.00204	0.0061	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IFNG—periodontitis	0.00201	0.00602	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—periodontitis	0.00197	0.0059	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—FGF2—periodontitis	0.00196	0.00586	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CXCL8—periodontitis	0.00187	0.00559	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.00186	0.00555	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.00182	0.00545	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GGT1—periodontitis	0.00178	0.00531	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.00176	0.00525	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.00175	0.00524	CbGpPWpGaD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.00172	0.00515	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—IL1B—periodontitis	0.0017	0.00508	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP9—periodontitis	0.00169	0.00506	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.00157	0.0047	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—TGFB1—periodontitis	0.00143	0.00427	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TGFB1—periodontitis	0.0014	0.00417	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—VDR—periodontitis	0.00133	0.00399	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00128	0.00382	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PPARA—periodontitis	0.00127	0.0038	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.00124	0.00372	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00123	0.00367	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—IL6—periodontitis	0.00121	0.0036	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC52A3—periodontitis	0.00118	0.00352	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—FGF2—periodontitis	0.00115	0.00344	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL3—periodontitis	0.00114	0.0034	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—PPARA—periodontitis	0.00113	0.00336	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.00112	0.00335	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—IL6—periodontitis	0.00105	0.00314	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—VDR—periodontitis	0.00102	0.00304	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—IL6—periodontitis	0.000963	0.00288	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000958	0.00286	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—periodontitis	0.000891	0.00266	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000867	0.00259	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	0.000865	0.00258	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARA—periodontitis	0.000857	0.00256	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—periodontitis	0.000827	0.00247	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VIP—periodontitis	0.000823	0.00246	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000811	0.00242	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—VDR—periodontitis	0.000783	0.00234	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000758	0.00226	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCR2—periodontitis	0.000733	0.00219	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—periodontitis	0.000719	0.00215	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ACP5—periodontitis	0.000694	0.00207	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL3—periodontitis	0.000668	0.002	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARA—periodontitis	0.00066	0.00197	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GGT1—periodontitis	0.000659	0.00197	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—VDR—periodontitis	0.000642	0.00192	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	0.000625	0.00187	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00062	0.00185	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	0.000584	0.00174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR2—periodontitis	0.00057	0.0017	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRB1—periodontitis	0.000568	0.0017	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—periodontitis	0.000565	0.00169	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARA—periodontitis	0.000542	0.00162	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—VDR—periodontitis	0.000489	0.00146	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VIP—periodontitis	0.000483	0.00144	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK1—periodontitis	0.000465	0.00139	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP3—periodontitis	0.000432	0.00129	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCR2—periodontitis	0.00043	0.00129	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARA—periodontitis	0.000413	0.00123	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000403	0.00121	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GGT1—periodontitis	0.000386	0.00115	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—VDR—periodontitis	0.000377	0.00113	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000344	0.00103	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR2—periodontitis	0.000335	0.001	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRB1—periodontitis	0.000333	0.000996	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARA—periodontitis	0.000318	0.00095	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—periodontitis	0.000281	0.00084	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARA—periodontitis	0.000276	0.000825	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK1—periodontitis	0.000273	0.000815	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF2—periodontitis	0.000254	0.000759	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP3—periodontitis	0.000254	0.000758	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—periodontitis	0.000222	0.000664	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ACP5—periodontitis	0.000202	0.000605	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—periodontitis	0.000201	0.0006	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—periodontitis	0.00018	0.000537	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—periodontitis	0.000166	0.000495	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—periodontitis	0.000165	0.000493	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF2—periodontitis	0.000149	0.000445	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—periodontitis	0.00013	0.00039	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—periodontitis	0.000125	0.000373	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—periodontitis	0.000118	0.000352	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GGT1—periodontitis	0.000113	0.000337	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—periodontitis	9.72e-05	0.00029	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARA—periodontitis	8.06e-05	0.000241	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—periodontitis	7.32e-05	0.000219	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—periodontitis	5.24e-05	0.000157	CbGpPWpGaD
